Canopy Growth Completes Acquisition of MTL Cannabis Creating Canada’s Leading Medical Cannabis Business By Revenue.

Canopy is now Canada's largest medical cannabis provider after the purchase of MTL Cannabis and hopes to turn a $100 million loss into profit.

For investors who have bought the dip on Canopy Growth amid its tailspin, they've been rewarded with significant losses. And ...

The MarketWatch News Department was not involved in the creation of this content. This news release constitutes a "designated news release" for the purposes of Canopy Growth's prospectus supplement ...

Detailed price information for Canopy Growth Corp (CGC-Q) from The Globe and Mail including charting and trades.

Canopy Growth is a large marijuana company with an increasingly diversified business. It is also a money-losing penny stock. 10 stocks we like better than Canopy Growth › Canopy Growth (NASDAQ: CGC) ...

Canopy Growth's latest quarter was decent, with the company making progress on the bottom line. Some investors are hoping that positive regulatory developments in the U.S. could be a turning point.

The MarketWatch News Department was not involved in the creation of this content. Aggregate prepayments totaling US$50 million completed under agreement with lenders are expected to reduce annual cash ...

Appointment finalizes CFO transition and reinforces Canopy Growth’s focus on operational discipline, financial stability, and long-term value creation Mr. Stewart’s appointment supports the continued ...

Detailed price information for Canopy Growth Corp (CGC-Q) from The Globe and Mail including charting and trades.